15/05/2017
A sporadic neurodegenerative tauopathy.
Both cortical (pyramidal and nonpyramidal) and subcortical abnormalities are seen.
Both neurons and glial cells are involved.
Cortical loss, predominantly affecting motor and premotor regions, may distinguish this disorderfrom progressive supranuclear palsy.
More common in women.
Typically, presents between the ages of 50 and 80 years.
CLINICAL PRESENTATION
Insidious onset and progressive course
Cortical dysfunction including at least 1 of the following:
Focal or asymmetric ideomotor apraxia,
("My hand/leg has a mind of its own.")
Cortical (parietal) sensory loss
Visual or tactile spatial neglect
Constructional apraxia
Focal or asymmetric myoclonus
Apraxia of speech or nonfluent aphasia
Extrapyramidal dysfunction,
including at least 1 of the following:
Focal or asymmetric appendicular rigidity
(unresponsive to levodopa)
Focal or asymmetric appendicular dystonia
Unusual presentations, for example, primary
progressive aphasia and progressive buccofacial apraxia,
The presence of prominent delusions or hallucinations
(not related to levodopa) suggests
the patient does not have CBGD;
they are more characteristic of diffuse Lewy body disease.
DIFFERENTIAL DIAGNOSIS.
Alzheimer Disease Imaging, Anterior Circulation Stroke,
Apraxia and Related Syndromes, CNS Whipple Disease,
Cardioembolic Stroke, CML, Creutzfeldt-Jakob Disease
Dementia With Lewy Bodies, Epilepsia Partialis Continua
Frontotemporal dementia, Glioblastoma Multiforme
Huntington Disease, Hydrocephalus,
Marchiafava-Bignami Disease, Multiple System Atrophy
Neuroacanthocytosis, Neuroacanthocytosis Syndromes
Neurosyphilis, Olivopontocerebellar Atrophy
Parkinson Disease, Pick Disease,
Progressive Supranuclear Palsy,
Striatonigral Degeneration, Subdural Hematoma
Vitamin B-12 Associated Neurological Diseases,
Vitamin E-Associated Neurological Diseases,
Wilson Disease,
WORK UP.
Ceruloplasmin, B-12 level, Rapid plasma reagin (RPR)
or (VDRL), TSH,
and consider thyroid autoantibody screening,
Electrolytes, CBC with differential and platelets
(ANA), (ESR), liver function tests, and ammonia level
Manual smear for acanthocytes
or genetic testing for Huntington disease
if patient has chorea.
Lumbar puncture (LP) may be done to examine
cerebrospinal fluid (CSF) for cells and elevated protein;
the polymerase chain reaction (PCR) test for the
organism Tropheryma whippleii should also be done
MRI OF BRAIN
This study is particularly helpful in evaluating the size
and appearance of the midbrain if any disturbance of
eye movements is noted
and progressive supranuclear palsy is being considered.
Midbrain size should be relatively normal in
cortical basal ganglionic degeneration (CBGD).
Cortical atrophy usually occurs, and this can be more
localized to the central sulci/supplementary motor area
(SMA) and superior frontal gyrus than to the
temporal/parietal cortex (the latter pattern is seen
in dementia of the Alzheimer type).
Abnormal signal in basal ganglia can occur with
metal deposition in Wilson disease or
Hallervorden-Spatz disease.
Functional brain imaging is not generally needed,
but it can be helpful in some patients to document that
cognitive changes are neurological and not psychological
in origin.